Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
2003

Managing Serious Adverse Events from Ivermectin Treatment in Co-endemic Areas

publication Evidence: moderate

Author Information

Author(s): Haselow Nancy J, Akame Julie, Evini Cyrille, Akongo Serge

Primary Institution: Helen Keller International

Hypothesis

How can community-directed treatment with ivermectin be adapted to minimize serious adverse events in areas co-endemic for onchocerciasis and loiasis?

Conclusion

A reinforced communication strategy is essential to motivate community participation in ivermectin treatment despite the risks of serious adverse events.

Supporting Evidence

  • Serious adverse events have been reported in areas co-endemic for loiasis and onchocerciasis.
  • Community participation is critical for the success of ivermectin treatment programs.
  • Effective communication strategies can help reduce fears associated with ivermectin side effects.

Takeaway

When people in certain areas take a medicine called ivermectin, they can sometimes feel really sick. To help them feel better about taking it, we need to talk to them more and explain how to stay safe.

Methodology

The review discusses the need for better communication and management strategies based on community-level research and experiences from previous ivermectin treatment programs.

Potential Biases

Potential biases may arise from the community's fear and misconceptions about ivermectin side effects.

Limitations

The study highlights the lack of adequate health education and community participation in managing serious adverse events.

Participant Demographics

The study focuses on communities in Cameroon co-endemic for onchocerciasis and loiasis.

Digital Object Identifier (DOI)

10.1186/1475-2883-2-S1-S10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication